Placebo-controlled study of pramiracetam in young males with memory and cognitive problems resulting from head injury and anoxia.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/1786500
Conclusion of this study
The results of the study indicate that subject performance in measures of memory, especially delayed recall, evidenced clinically significant improvements after the administration of pramiracetam sulphate as compared to placebo. This improvement was maintained during an 18-month open-trial period on the medication as well as during a 1-month follow-up period after the pramiracetam was discontinued.
Supplements analyzed in this study
|
Health conditions analyzed in this study
No health conditions information for this study.Functions related to this study
|
||
|
Body systems related to this study
Nervous System |